Vivos Therapeutics Inc is a medical technology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VVOS is expected to report earnings to fall 32.26% to -20 cents per share on November 18
Q3'26
Est.
$-0.21
Q2'26
Beat
by $0.06
Q1'26
Missed
by $0.07
Q4'25
Missed
by $0.08
Q3'25
Missed
by $0.01
The last earnings report on August 17 showed earnings per share of -31 cents, beating the estimate of -37 cents. With 237.50K shares outstanding, the current market capitalization sits at 2.70M.